Pharmaceutical Contract Manufacturing Market Size Worth USD 179.4 Billion by 2030 at 6% CAGR | MRFR

Pharmaceutical Contract Manufacturing Market Research Report By Types (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Market)-Forecast till 2030

The Pharmaceutical contract manufacturing market Size was valued at USD 112.6 billion in 2021 and is projected to grow from USD 119.3 Billion in 2022 to USD 179.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period (2022 – 2030). Rising demand for biological therapies, patent expiry and increasing demand for generic drugs, and increasing demand for gene and cell therapies are the key market drivers enhancing the market growth.

Pharmaceutical contract manufacturing refers to the outsourcing of the manufacturing of drug products and related packaging services to a third-party company. This arrangement allows pharmaceutical companies to access specialized expertise, technology, and manufacturing capabilities that they may not have in-house. The third-party manufacturer, known as a contract manufacturer, provides services such as formulation development, scale-up, production, packaging, and labeling, and may also offer regulatory support and quality control. The pharmaceutical contract manufacturing market refers to the industry of companies that offer these services to the pharmaceutical industry. The COVID-19 pandemic and the sudden increase in demand for medical supplies and drugs to treat COVID-19 patients put a strain on the supply chain, leading to disruptions in the production and delivery of essential drugs and medical supplies.

Get Free Sample PDF Brochure @ 

This caused a shortage of raw materials and ingredients, which in turn impacted the production processes of contract manufacturers. the pandemic led to travel restrictions, lockdowns, and border closures, making it difficult for contract manufacturers to transport goods and raw materials. This impacted their ability to deliver products on time and caused delays in the supply chain. The rapid increase in demand for COVID-19-related products such as personal protective equipment (PPE), antiviral drugs, and vaccines created new business opportunities for contract manufacturers. The industry is expected to recover and grow as the world continues to deal with the pandemic and the demand for medical supplies and drugs remains high.

Pharmaceutical Contract Manufacturing Market Segmentation

The Global Pharmaceutical Contract Manufacturing market has been segmented into types.

Based on the type, the market has been segmented into Active Pharmaceutical Ingredient (API) Manufacturing (Small Molecule, Large Molecule, High Potency API (HPAPI)), Finished Dosage Formulation (FDF) Development and Manufacturing (Solid Dose Formulation, Liquid Dose Formulation, Injectable Dose Formulation), Secondary Packaging)

Key Players

Top key players in the market are

• Wuxi Jiajian Medical Instruments Co. Ltd.
• Zepter International
• Acumedic Limited
• 3B Scientific GmbH
• Asia-Med Gmbh
• Schwa-medico
• Qingdao Great Fortune Co. Ltd
• SIRIN Corporation
• MKW Laser System

Browse In-depth Market Research Report (76 Pages) on Pharmaceutical Contract Manufacturing:

Pharmaceutical Contract Manufacturing Market Regional Analysis

North America is currently the largest market for pharmaceutical contract manufacturing, with the United States being the major contributor to the market’s growth. The region has a well-established pharmaceutical industry, a high adoption rate of advanced pharmaceutical manufacturing technologies, and a growing number of partnerships and collaborations among industry players, which has propelled the growth of the market in North America.

Europe is the second-largest market for pharmaceutical contract manufacturing, and the growth is primarily driven by the increasing demand for cost-effective drug manufacturing solutions and the growing need for efficient pharmaceutical operations. Moreover, the presence of a well-established pharmaceutical industry and the increasing investments in pharmaceutical manufacturing technologies have also contributed to the growth of the market in Europe.

The Asia Pacific region is expected to witness significant growth in the pharmaceutical contract manufacturing market due to the increasing demand for cost-effective drug manufacturing solutions, the rising healthcare expenditure, and the growing adoption of advanced pharmaceutical manufacturing technologies. Moreover, the increasing number of partnerships and collaborations among industry players and the availability of a large pool of skilled professionals are expected to drive the growth of the market in the region

Browse Related Reports at

Active Pharmaceutical Ingredients Market Research Report Information By Manufacturing Process (Captive Manufacturing and Contract Manufacturing), By Type of Synthesis (Synthetic and Biotech), By API Formulation (Generic API and Branded/Innovative API), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, and others), By Molecules (Large Molecule and Small Molecule), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Contract Research Organization (CRO) Market Research Report: Information By Type (Drug Discovery, Clinical Development), By Clinical trial (Preclinical Trials, Phase I, Phase II, Phase III, Phase IV, Others), By End User (Academic institutes, Pharmaceutical companies, Medical service companies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Gene Therapy Market Research Report: Information By Product Type (Kymriah, Luxturna, Yescarta, Zolgensma, Zynteglo), By Indication (Oncology And Genetic Diseases), By End Users(Hospitals & Clinics, Specialty Treatment Centers), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website:

No Byline Policy

Editorial Guidelines

Corrections Policy

Source